GUTS
Fractyl HealthยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
GUTS Profile
Fractyl Health, Inc.
A diabetes and obesity therapy research and development company
Life Science Tools and Services
08/30/2010
02/02/2024
NASDAQ Stock Exchange
107
12-31
Common stock
3 Van de Graaff Drive, Suite 200, Burlington, MA 01803
--
Fractyl Health, Inc., was incorporated under the laws of the State of Delaware on August 30, 2010. The company is a metabolic therapy company focused on pioneering new approaches to the treatment of metabolic diseases, including type 2 diabetes and obesity. About 100 million people in the United States have prediabetes and obesity, and another 25 million have diabetes and are on medication, according to the Centers for Disease Control and the International Diabetes Federation. The company's goal is to develop durable disease-modifying therapies designed to provide long-term maintenance of metabolic health without the need for lifelong treatment by targeting the organ-level root causes of T2D and obesity.
